Gross Tumor Volume
The Gross Tumor Volume (GTV) is the gross palpable or visible /demonstrable extent and location of the malignant growth.
Clinical Target Volume
The Clinical Target Volume (CTV) is a tissue volume that contains a GTV and/or subclinical microscopic malignant disease, which has to be eliminated. This volume thus has to be treated adequately in order to achieve the aim of therapy: cure or palliation.
The CTV is thus an anatomical-clinical concept, that has to be defined before a choice of treatment modality and technique is made.
For external beam therapy, margins will have to be added around the CTV to compensate for the effects of organ and patient movements and inaccuracies in beam and patient set up. This leads to the concept of Planning Target Volume (PTV).
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Planning Target Volume
The Planning Target Volume (PTV) is a geometrical concept, and it is defined to select appropriate beam sizes and beam arrangements, taking into consideration the net effect of all the possible geometrical variations and inaccuracies in order to ensure that the prescribed dose is actually absorbed in the CTV.
The Planning Target Volume is thus a static, geometrical concept, used for treatment planning and for specification of dose. Its size and shape depend primarily on the CTV, but also on the treatment technique used.
Depending on treatment technique, two further volumes can be identified: Treated Volume and Irradiated Volume.
Treated Volume
The Treated Volume is the volume enclosed by an isodose surface, selected and specified by the radiation oncologist as being appropriate to achieve the purpose of treatment (e.g., tumor eradication, palliation).
Irradiated Volume
The Irradiated Volume is that tissue volume which receives a dose that is considered significant in relation to normal tissue tolerance.
Organs at Risk
Furthermore, consideration has to be given to normal tissues.
Organs at risk are normal tissues whose radiation sensitivity may significantly influence treatment planning and /or prescribed dose.
General Recommendations for Reporting Dose
The dose at or near the center of the Planning Target Volume, as well as the maximum and the minimum dose to the PTV, shall always be reported. Additional information (such as average dose and its standard deviation, dose/volume histograms), when available, may be useful.
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The ICRU Reference Point
The present system of recommendations for reporting is based on the selection of a point within the PTV, which is referred to as the JCRU Reference Point.
The JCR U Reference Point shall be selected according to the following general criteria: -the dose at the point should be clinically relevant and representative of the dose throughout the Planning Target Volume (PTV), -the point should be easy to define in a clear and unambiguous way, -the point should be selected where the dose can be accurately determined (physical accuracy), -the point should be selected in a region where there is no steep dose gradient. These recommendations will be fulfilled if the ICRU Reference Point is located firstly, at the center, or in the central parts, of the Planning Target Volume, and secondly, on or near the central axis of the beam(s).
In some situations, it is not possible to define the ICRU Reference Point at the center of the Planning Target Volume. In these conditions, one has to select the ICRU Reference Point inside the tissues represented by the PTV, and in a place where dose specification is considered to be meaningful. Such a place could be the region where the tumor cell density is considered to be at its maximum.
The dose at the ICRU Reference Point is the JCRU Reference Dose.
The Dose Variation Throughout the Planning Target Volume
As a minimum requirement, the maximum and the minimum dose to the PTV shall be reported together with the dose at the ICRU Reference Point. The three dose values then represent the dose to the Clinical Target Volume and the dose variation.
Other dose values considered to be relevant (e.g., average dose and its standard deviation, dose/volume histograms, biologically weighted doses), when available, should also be reported.
Three Levels of Dose Evaluation for Reporting
The level of completeness and accuracy of reporting therapeutic irradiation depends to a large extent on the situation in the department and on the aim of the treatment. For different clinical and practical consid-erations, different levels of ambition for dose evaluation can be identified:
Level 1: Basic Techniques
The minimum requirements for reporting can be followed in all centers including those with restricted therapy equipment, dosimetric, computer, and staff facilities. This basic level may sometimes be sufficient in any center when simple treatments are performed (e.g., some palliative treatments).
At this level, it is assumed that the dose at the ICRU Reference Point and an estimation of the maximum and the minimum doses to the PTV can be determined.
Level 2: Advanced Techniques
The standards of dose planning at this level allow the exchange between different centers of more complete and relevant information. At this level, it is assumed that the GTV, CTV, and PTV can be defined in one or more planes (sections) using reliable patient data acquisition tools, and/or modern imaging techniques under reliable conditions (e.g., a series of CT and/or MRI scans). It is also assumed that complete dose distributions are computed in the central plane and in other planes (sections) using only central axis dose data, and with inhomogeneity corrections, when appropriate.
Level 3: Developmental Techniques
The performance of dose planning at level 3 provides for the development of new techniques and clinical research in radiotherapy. At this level, 3-D dose computation of any beam arrangement (such as non-coplanar beams) and dose/volume histograms are available. NB: In summary, the 3 levels could be described as follows: Level 1: Only the dose at the Reference Point and its variation along a central beam axis is available. Level 2: The dose distribution can be computed for plane(s). Level 3: The dose distribution can be computed for volumes. At any level, the dose at the ICRU Reference Point and the best estimation of the maximum and the minimum dose to the PTV should be reported.
